BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37174687)

  • 1. CRMP2 Participates in Regulating Mitochondrial Morphology and Motility in Alzheimer's Disease.
    Brustovetsky T; Khanna R; Brustovetsky N
    Cells; 2023 Apr; 12(9):. PubMed ID: 37174687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of CRMP2 in Regulation of Mitochondrial Morphology and Motility in Huntington's Disease.
    Brustovetsky T; Khanna R; Brustovetsky N
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRMP2 Is Involved in Regulation of Mitochondrial Morphology and Motility in Neurons.
    Brustovetsky T; Khanna R; Brustovetsky N
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage.
    Manczak M; Reddy PH
    Hum Mol Genet; 2012 Jun; 21(11):2538-47. PubMed ID: 22367970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression.
    Cole AR; Noble W; van Aalten L; Plattner F; Meimaridou R; Hogan D; Taylor M; LaFrancois J; Gunn-Moore F; Verkhratsky A; Oddo S; LaFerla F; Giese KP; Dineley KT; Duff K; Richardson JC; Yan SD; Hanger DP; Allan SM; Sutherland C
    J Neurochem; 2007 Nov; 103(3):1132-44. PubMed ID: 17683481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.
    Baek SH; Park SJ; Jeong JI; Kim SH; Han J; Kyung JW; Baik SH; Choi Y; Choi BY; Park JS; Bahn G; Shin JH; Jo DS; Lee JY; Jang CG; Arumugam TV; Kim J; Han JW; Koh JY; Cho DH; Jo DG
    J Neurosci; 2017 May; 37(20):5099-5110. PubMed ID: 28432138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
    Manczak M; Kandimalla R; Fry D; Sesaki H; Reddy PH
    Hum Mol Genet; 2016 Dec; 25(23):5148-5166. PubMed ID: 27677309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockage of GSK3β-mediated Drp1 phosphorylation provides neuroprotection in neuronal and mouse models of Alzheimer's disease.
    Yan J; Liu XH; Han MZ; Wang YM; Sun XL; Yu N; Li T; Su B; Chen ZY
    Neurobiol Aging; 2015 Jan; 36(1):211-27. PubMed ID: 25192600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRMP2 hyperphosphorylation is characteristic of Alzheimer's disease and not a feature common to other neurodegenerative diseases.
    Williamson R; van Aalten L; Mann DM; Platt B; Plattner F; Bedford L; Mayer J; Howlett D; Usardi A; Sutherland C; Cole AR
    J Alzheimers Dis; 2011; 27(3):615-25. PubMed ID: 21860090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington's disease.
    Haun F; Nakamura T; Shiu AD; Cho DH; Tsunemi T; Holland EA; La Spada AR; Lipton SA
    Antioxid Redox Signal; 2013 Oct; 19(11):1173-84. PubMed ID: 23641925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neuronal model of Alzheimer's disease: an insight into the mechanisms of oxidative stress-mediated mitochondrial injury.
    Sompol P; Ittarat W; Tangpong J; Chen Y; Doubinskaia I; Batinic-Haberle I; Abdul HM; Butterfield DA; St Clair DK
    Neuroscience; 2008 Apr; 153(1):120-30. PubMed ID: 18353561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment.
    Watamura N; Toba J; Yoshii A; Nikkuni M; Ohshima T
    J Neurosci Res; 2016 Jan; 94(1):15-26. PubMed ID: 26400044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5.
    Moutal A; François-Moutal L; Perez-Miller S; Cottier K; Chew LA; Yeon SK; Dai J; Park KD; Khanna M; Khanna R
    Mol Neurobiol; 2016 Apr; 53(3):1959-1976. PubMed ID: 25846820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AP39, a Mitochondria-Targeted Hydrogen Sulfide Donor, Supports Cellular Bioenergetics and Protects against Alzheimer's Disease by Preserving Mitochondrial Function in APP/PS1 Mice and Neurons.
    Zhao FL; Fang F; Qiao PF; Yan N; Gao D; Yan Y
    Oxid Med Cell Longev; 2016; 2016():8360738. PubMed ID: 27057285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Protective Effect of Icariin on Mitochondrial Transport and Distribution in Primary Hippocampal Neurons from 3× Tg-AD Mice.
    Chen Y; Han S; Huang X; Ni J; He X
    Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26828481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau-tubulin kinase 1 and amyloid-β peptide induce phosphorylation of collapsin response mediator protein-2 and enhance neurite degeneration in Alzheimer disease mouse models.
    Ikezu S; Ingraham Dixie KL; Koro L; Watanabe T; Kaibuchi K; Ikezu T
    Acta Neuropathol Commun; 2020 Feb; 8(1):12. PubMed ID: 32019603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased CRMP2 phosphorylation is observed in Alzheimer's disease; does this tell us anything about disease development?
    Soutar MP; Thornhill P; Cole AR; Sutherland C
    Curr Alzheimer Res; 2009 Jun; 6(3):269-78. PubMed ID: 19519308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synapsin-Promoted Caveolin-1 Overexpression Maintains Mitochondrial Morphology and Function in PSAPP Alzheimer's Disease Mice.
    Wang S; Ichinomiya T; Terada Y; Wang D; Patel HH; Head BP
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model.
    Long AN; Owens K; Schlappal AE; Kristian T; Fishman PS; Schuh RA
    BMC Neurol; 2015 Mar; 15():19. PubMed ID: 25884176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.